nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—CXCL8—ovarian cancer	0.652	1	CbGaD
Tolmetin—MPO—Carboplatin—ovarian cancer	0.158	1	CbGbCtD
Tolmetin—PTGS2—ovarian follicle—ovarian cancer	0.00642	0.128	CbGeAlD
Tolmetin—TDO2—female reproductive system—ovarian cancer	0.0036	0.0716	CbGeAlD
Tolmetin—CXCL8—myometrium—ovarian cancer	0.0034	0.0676	CbGeAlD
Tolmetin—PTGS1—oviduct—ovarian cancer	0.00295	0.0586	CbGeAlD
Tolmetin—CXCL8—uterine cervix—ovarian cancer	0.00265	0.0526	CbGeAlD
Tolmetin—CXCL8—decidua—ovarian cancer	0.00252	0.0502	CbGeAlD
Tolmetin—CXCL8—endometrium—ovarian cancer	0.0024	0.0476	CbGeAlD
Tolmetin—TDO2—lymph node—ovarian cancer	0.00211	0.0419	CbGeAlD
Tolmetin—CXCL8—bone marrow—ovarian cancer	0.00187	0.0372	CbGeAlD
Tolmetin—CXCL8—female gonad—ovarian cancer	0.00181	0.0359	CbGeAlD
Tolmetin—CXCL8—vagina—ovarian cancer	0.00179	0.0357	CbGeAlD
Tolmetin—CXCL8—testis—ovarian cancer	0.0016	0.0318	CbGeAlD
Tolmetin—MPO—epithelium—ovarian cancer	0.00156	0.031	CbGeAlD
Tolmetin—Thrombocytopenia—Altretamine—ovarian cancer	0.00125	0.0199	CcSEcCtD
Tolmetin—CXCL8—lymph node—ovarian cancer	0.00116	0.0231	CbGeAlD
Tolmetin—MPO—bone marrow—ovarian cancer	0.0011	0.0218	CbGeAlD
Tolmetin—Lymphadenopathy—Chlorambucil—ovarian cancer	0.00108	0.0172	CcSEcCtD
Tolmetin—Haemolytic anaemia—Chlorambucil—ovarian cancer	0.00102	0.0163	CcSEcCtD
Tolmetin—MPO—testis—ovarian cancer	0.000936	0.0186	CbGeAlD
Tolmetin—Asthenia—Altretamine—ovarian cancer	0.000915	0.0146	CcSEcCtD
Tolmetin—PTGS2—myometrium—ovarian cancer	0.000902	0.0179	CbGeAlD
Tolmetin—Haemolytic anaemia—Melphalan—ovarian cancer	0.00089	0.0142	CcSEcCtD
Tolmetin—PTGS2—embryo—ovarian cancer	0.000868	0.0173	CbGeAlD
Tolmetin—Anaphylactoid reaction—Topotecan—ovarian cancer	0.000848	0.0135	CcSEcCtD
Tolmetin—Dizziness—Altretamine—ovarian cancer	0.000843	0.0134	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Chlorambucil—ovarian cancer	0.00083	0.0132	CcSEcCtD
Tolmetin—Vomiting—Altretamine—ovarian cancer	0.000811	0.0129	CcSEcCtD
Tolmetin—Nausea—Altretamine—ovarian cancer	0.000757	0.0121	CcSEcCtD
Tolmetin—PTGS1—epithelium—ovarian cancer	0.000741	0.0147	CbGeAlD
Tolmetin—PTGS1—uterine cervix—ovarian cancer	0.000735	0.0146	CbGeAlD
Tolmetin—PTGS2—epithelium—ovarian cancer	0.000708	0.0141	CbGeAlD
Tolmetin—PTGS2—uterine cervix—ovarian cancer	0.000702	0.014	CbGeAlD
Tolmetin—Body temperature increased—Carboplatin—ovarian cancer	0.000696	0.0111	CcSEcCtD
Tolmetin—Stomatitis—Chlorambucil—ovarian cancer	0.000692	0.011	CcSEcCtD
Tolmetin—Indomethacin—CXCL8—ovarian cancer	0.000687	0.659	CrCbGaD
Tolmetin—MPO—lymph node—ovarian cancer	0.000679	0.0135	CbGeAlD
Tolmetin—PTGS1—endometrium—ovarian cancer	0.000665	0.0132	CbGeAlD
Tolmetin—Blood pressure increased—Paclitaxel—ovarian cancer	0.00065	0.0104	CcSEcCtD
Tolmetin—Weight increased—Topotecan—ovarian cancer	0.000645	0.0103	CcSEcCtD
Tolmetin—PTGS2—endometrium—ovarian cancer	0.000635	0.0126	CbGeAlD
Tolmetin—Stomatitis—Topotecan—ovarian cancer	0.000616	0.00982	CcSEcCtD
Tolmetin—PTGS1—uterus—ovarian cancer	0.000612	0.0122	CbGeAlD
Tolmetin—Stomatitis—Melphalan—ovarian cancer	0.000604	0.00961	CcSEcCtD
Tolmetin—Erythema multiforme—Chlorambucil—ovarian cancer	0.000603	0.0096	CcSEcCtD
Tolmetin—Epistaxis—Topotecan—ovarian cancer	0.000596	0.0095	CcSEcCtD
Tolmetin—PTGS2—uterus—ovarian cancer	0.000585	0.0116	CbGeAlD
Tolmetin—Hepatitis—Melphalan—ovarian cancer	0.000556	0.00885	CcSEcCtD
Tolmetin—Blood pressure increased—Docetaxel—ovarian cancer	0.000551	0.00878	CcSEcCtD
Tolmetin—PTGS1—female reproductive system—ovarian cancer	0.00055	0.0109	CbGeAlD
Tolmetin—Weight decreased—Vinorelbine—ovarian cancer	0.000549	0.00874	CcSEcCtD
Tolmetin—Stomatitis—Vinorelbine—ovarian cancer	0.000527	0.0084	CcSEcCtD
Tolmetin—PTGS2—female reproductive system—ovarian cancer	0.000526	0.0105	CbGeAlD
Tolmetin—Cardiac failure congestive—Paclitaxel—ovarian cancer	0.000521	0.00829	CcSEcCtD
Tolmetin—Agranulocytosis—Vinorelbine—ovarian cancer	0.000505	0.00804	CcSEcCtD
Tolmetin—PTGS1—female gonad—ovarian cancer	0.000501	0.00996	CbGeAlD
Tolmetin—Visual disturbance—Paclitaxel—ovarian cancer	0.000498	0.00794	CcSEcCtD
Tolmetin—PTGS1—vagina—ovarian cancer	0.000498	0.00989	CbGeAlD
Tolmetin—PTGS2—bone marrow—ovarian cancer	0.000497	0.00987	CbGeAlD
Tolmetin—PTGS2—female gonad—ovarian cancer	0.000479	0.00952	CbGeAlD
Tolmetin—PTGS2—vagina—ovarian cancer	0.000476	0.00946	CbGeAlD
Tolmetin—PTGS1—testis—ovarian cancer	0.000444	0.00883	CbGeAlD
Tolmetin—Thrombocytopenia—Chlorambucil—ovarian cancer	0.000444	0.00707	CcSEcCtD
Tolmetin—Cardiac failure congestive—Docetaxel—ovarian cancer	0.000441	0.00703	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.000425	0.00677	CcSEcCtD
Tolmetin—Visual disturbance—Docetaxel—ovarian cancer	0.000422	0.00673	CcSEcCtD
Tolmetin—Chest pain—Topotecan—ovarian cancer	0.000421	0.0067	CcSEcCtD
Tolmetin—Chest pain—Melphalan—ovarian cancer	0.000412	0.00656	CcSEcCtD
Tolmetin—Glossitis—Epirubicin—ovarian cancer	0.000404	0.00643	CcSEcCtD
Tolmetin—Anaphylactic shock—Topotecan—ovarian cancer	0.000403	0.00642	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.0004	0.00637	CcSEcCtD
Tolmetin—Dyspepsia—Chlorambucil—ovarian cancer	0.000399	0.00635	CcSEcCtD
Tolmetin—Oedema—Melphalan—ovarian cancer	0.000395	0.00629	CcSEcCtD
Tolmetin—Anaphylactic shock—Melphalan—ovarian cancer	0.000395	0.00629	CcSEcCtD
Tolmetin—Thrombocytopenia—Topotecan—ovarian cancer	0.000395	0.00629	CcSEcCtD
Tolmetin—Thrombocytopenia—Melphalan—ovarian cancer	0.000387	0.00616	CcSEcCtD
Tolmetin—Dysuria—Paclitaxel—ovarian cancer	0.000382	0.00608	CcSEcCtD
Tolmetin—Glossitis—Doxorubicin—ovarian cancer	0.000373	0.00595	CcSEcCtD
Tolmetin—Weight increased—Paclitaxel—ovarian cancer	0.000371	0.00592	CcSEcCtD
Tolmetin—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00037	0.0059	CcSEcCtD
Tolmetin—Weight decreased—Paclitaxel—ovarian cancer	0.000369	0.00588	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.00036	0.00574	CcSEcCtD
Tolmetin—Urticaria—Chlorambucil—ovarian cancer	0.00036	0.00573	CcSEcCtD
Tolmetin—Chest pain—Vinorelbine—ovarian cancer	0.00036	0.00573	CcSEcCtD
Tolmetin—Abdominal pain—Chlorambucil—ovarian cancer	0.000358	0.0057	CcSEcCtD
Tolmetin—Body temperature increased—Chlorambucil—ovarian cancer	0.000358	0.0057	CcSEcCtD
Tolmetin—Renal failure—Paclitaxel—ovarian cancer	0.000358	0.0057	CcSEcCtD
Tolmetin—Dyspepsia—Topotecan—ovarian cancer	0.000355	0.00565	CcSEcCtD
Tolmetin—Stomatitis—Paclitaxel—ovarian cancer	0.000355	0.00565	CcSEcCtD
Tolmetin—Urinary tract infection—Paclitaxel—ovarian cancer	0.000354	0.00563	CcSEcCtD
Tolmetin—Blood urea increased—Epirubicin—ovarian cancer	0.000351	0.00559	CcSEcCtD
Tolmetin—Dyspepsia—Melphalan—ovarian cancer	0.000348	0.00554	CcSEcCtD
Tolmetin—Haematuria—Paclitaxel—ovarian cancer	0.000347	0.00553	CcSEcCtD
Tolmetin—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000345	0.0055	CcSEcCtD
Tolmetin—Constipation—Topotecan—ovarian cancer	0.000345	0.00549	CcSEcCtD
Tolmetin—Epistaxis—Paclitaxel—ovarian cancer	0.000343	0.00547	CcSEcCtD
Tolmetin—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000338	0.00538	CcSEcCtD
Tolmetin—Gastrointestinal pain—Topotecan—ovarian cancer	0.00033	0.00525	CcSEcCtD
Tolmetin—Asthenia—Chlorambucil—ovarian cancer	0.000325	0.00518	CcSEcCtD
Tolmetin—Blood urea increased—Doxorubicin—ovarian cancer	0.000325	0.00517	CcSEcCtD
Tolmetin—PTGS1—lymph node—ovarian cancer	0.000322	0.0064	CbGeAlD
Tolmetin—Urticaria—Topotecan—ovarian cancer	0.00032	0.0051	CcSEcCtD
Tolmetin—Body temperature increased—Topotecan—ovarian cancer	0.000319	0.00508	CcSEcCtD
Tolmetin—Abdominal pain—Topotecan—ovarian cancer	0.000319	0.00508	CcSEcCtD
Tolmetin—Lymphadenopathy—Epirubicin—ovarian cancer	0.000316	0.00504	CcSEcCtD
Tolmetin—Weight increased—Docetaxel—ovarian cancer	0.000315	0.00501	CcSEcCtD
Tolmetin—Visual impairment—Paclitaxel—ovarian cancer	0.000315	0.00501	CcSEcCtD
Tolmetin—Urticaria—Melphalan—ovarian cancer	0.000314	0.005	CcSEcCtD
Tolmetin—Weight decreased—Docetaxel—ovarian cancer	0.000313	0.00498	CcSEcCtD
Tolmetin—Diarrhoea—Chlorambucil—ovarian cancer	0.00031	0.00494	CcSEcCtD
Tolmetin—Erythema multiforme—Paclitaxel—ovarian cancer	0.000309	0.00492	CcSEcCtD
Tolmetin—PTGS2—lymph node—ovarian cancer	0.000308	0.00612	CbGeAlD
Tolmetin—Tinnitus—Paclitaxel—ovarian cancer	0.000305	0.00485	CcSEcCtD
Tolmetin—Renal failure—Docetaxel—ovarian cancer	0.000303	0.00483	CcSEcCtD
Tolmetin—Vascular purpura—Epirubicin—ovarian cancer	0.000302	0.00481	CcSEcCtD
Tolmetin—Stomatitis—Docetaxel—ovarian cancer	0.000301	0.00479	CcSEcCtD
Tolmetin—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000298	0.00474	CcSEcCtD
Tolmetin—Constipation—Vinorelbine—ovarian cancer	0.000295	0.0047	CcSEcCtD
Tolmetin—Lymphadenopathy—Doxorubicin—ovarian cancer	0.000293	0.00466	CcSEcCtD
Tolmetin—Epistaxis—Docetaxel—ovarian cancer	0.000291	0.00463	CcSEcCtD
Tolmetin—Asthenia—Topotecan—ovarian cancer	0.000289	0.00461	CcSEcCtD
Tolmetin—Vomiting—Chlorambucil—ovarian cancer	0.000288	0.00459	CcSEcCtD
Tolmetin—Agranulocytosis—Docetaxel—ovarian cancer	0.000288	0.00458	CcSEcCtD
Tolmetin—Asthenia—Melphalan—ovarian cancer	0.000283	0.00451	CcSEcCtD
Tolmetin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000282	0.00449	CcSEcCtD
Tolmetin—Flatulence—Paclitaxel—ovarian cancer	0.00028	0.00446	CcSEcCtD
Tolmetin—Purpura—Epirubicin—ovarian cancer	0.00028	0.00446	CcSEcCtD
Tolmetin—Vascular purpura—Doxorubicin—ovarian cancer	0.000279	0.00445	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000279	0.00444	CcSEcCtD
Tolmetin—Hepatitis—Docetaxel—ovarian cancer	0.000277	0.00441	CcSEcCtD
Tolmetin—Diarrhoea—Topotecan—ovarian cancer	0.000276	0.0044	CcSEcCtD
Tolmetin—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.000275	0.00439	CcSEcCtD
Tolmetin—Urticaria—Vinorelbine—ovarian cancer	0.000274	0.00437	CcSEcCtD
Tolmetin—Body temperature increased—Vinorelbine—ovarian cancer	0.000273	0.00434	CcSEcCtD
Tolmetin—Abdominal pain—Vinorelbine—ovarian cancer	0.000273	0.00434	CcSEcCtD
Tolmetin—Diarrhoea—Melphalan—ovarian cancer	0.00027	0.0043	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.00027	0.0043	CcSEcCtD
Tolmetin—Nausea—Chlorambucil—ovarian cancer	0.000269	0.00429	CcSEcCtD
Tolmetin—Visual impairment—Docetaxel—ovarian cancer	0.000267	0.00425	CcSEcCtD
Tolmetin—Dizziness—Topotecan—ovarian cancer	0.000267	0.00425	CcSEcCtD
Tolmetin—Erythema multiforme—Docetaxel—ovarian cancer	0.000262	0.00417	CcSEcCtD
Tolmetin—Purpura—Doxorubicin—ovarian cancer	0.000259	0.00413	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000258	0.00411	CcSEcCtD
Tolmetin—Vomiting—Topotecan—ovarian cancer	0.000256	0.00408	CcSEcCtD
Tolmetin—Headache—Topotecan—ovarian cancer	0.000253	0.00402	CcSEcCtD
Tolmetin—Vomiting—Melphalan—ovarian cancer	0.000251	0.004	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.00025	0.00398	CcSEcCtD
Tolmetin—Asthenia—Vinorelbine—ovarian cancer	0.000248	0.00394	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000243	0.00387	CcSEcCtD
Tolmetin—Chest pain—Paclitaxel—ovarian cancer	0.000242	0.00386	CcSEcCtD
Tolmetin—Nausea—Topotecan—ovarian cancer	0.00024	0.00382	CcSEcCtD
Tolmetin—Gastritis—Epirubicin—ovarian cancer	0.000239	0.00381	CcSEcCtD
Tolmetin—Diarrhoea—Vinorelbine—ovarian cancer	0.000236	0.00376	CcSEcCtD
Tolmetin—Nausea—Melphalan—ovarian cancer	0.000235	0.00374	CcSEcCtD
Tolmetin—Oedema—Paclitaxel—ovarian cancer	0.000232	0.0037	CcSEcCtD
Tolmetin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000232	0.0037	CcSEcCtD
Tolmetin—Dizziness—Vinorelbine—ovarian cancer	0.000228	0.00363	CcSEcCtD
Tolmetin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000227	0.00362	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000225	0.00358	CcSEcCtD
Tolmetin—Gastritis—Doxorubicin—ovarian cancer	0.000221	0.00352	CcSEcCtD
Tolmetin—Vomiting—Vinorelbine—ovarian cancer	0.000219	0.00349	CcSEcCtD
Tolmetin—Dysuria—Epirubicin—ovarian cancer	0.000218	0.00347	CcSEcCtD
Tolmetin—Headache—Vinorelbine—ovarian cancer	0.000216	0.00344	CcSEcCtD
Tolmetin—Weight increased—Epirubicin—ovarian cancer	0.000212	0.00338	CcSEcCtD
Tolmetin—Weight decreased—Epirubicin—ovarian cancer	0.000211	0.00336	CcSEcCtD
Tolmetin—Drowsiness—Epirubicin—ovarian cancer	0.000208	0.00331	CcSEcCtD
Tolmetin—Somnolence—Paclitaxel—ovarian cancer	0.000206	0.00329	CcSEcCtD
Tolmetin—Chest pain—Docetaxel—ovarian cancer	0.000205	0.00327	CcSEcCtD
Tolmetin—Nausea—Vinorelbine—ovarian cancer	0.000205	0.00326	CcSEcCtD
Tolmetin—Renal failure—Epirubicin—ovarian cancer	0.000204	0.00326	CcSEcCtD
Tolmetin—Dyspepsia—Paclitaxel—ovarian cancer	0.000204	0.00325	CcSEcCtD
Tolmetin—Stomatitis—Epirubicin—ovarian cancer	0.000203	0.00323	CcSEcCtD
Tolmetin—Urinary tract infection—Epirubicin—ovarian cancer	0.000202	0.00322	CcSEcCtD
Tolmetin—Dysuria—Doxorubicin—ovarian cancer	0.000202	0.00322	CcSEcCtD
Tolmetin—Constipation—Paclitaxel—ovarian cancer	0.000198	0.00316	CcSEcCtD
Tolmetin—Haematuria—Epirubicin—ovarian cancer	0.000198	0.00316	CcSEcCtD
Tolmetin—Oedema—Docetaxel—ovarian cancer	0.000197	0.00313	CcSEcCtD
Tolmetin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000197	0.00313	CcSEcCtD
Tolmetin—Weight increased—Doxorubicin—ovarian cancer	0.000196	0.00313	CcSEcCtD
Tolmetin—Epistaxis—Epirubicin—ovarian cancer	0.000196	0.00313	CcSEcCtD
Tolmetin—Weight decreased—Doxorubicin—ovarian cancer	0.000195	0.00311	CcSEcCtD
Tolmetin—Agranulocytosis—Epirubicin—ovarian cancer	0.000194	0.00309	CcSEcCtD
Tolmetin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000193	0.00307	CcSEcCtD
Tolmetin—Drowsiness—Doxorubicin—ovarian cancer	0.000192	0.00307	CcSEcCtD
Tolmetin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00019	0.00302	CcSEcCtD
Tolmetin—Renal failure—Doxorubicin—ovarian cancer	0.000189	0.00301	CcSEcCtD
Tolmetin—Stomatitis—Doxorubicin—ovarian cancer	0.000188	0.00299	CcSEcCtD
Tolmetin—Urinary tract infection—Doxorubicin—ovarian cancer	0.000187	0.00298	CcSEcCtD
Tolmetin—Hepatitis—Epirubicin—ovarian cancer	0.000187	0.00297	CcSEcCtD
Tolmetin—Aminohippurate—ABCB1—ovarian cancer	0.000186	0.178	CrCbGaD
Tolmetin—Urticaria—Paclitaxel—ovarian cancer	0.000184	0.00294	CcSEcCtD
Tolmetin—Haematuria—Doxorubicin—ovarian cancer	0.000184	0.00292	CcSEcCtD
Tolmetin—Abdominal pain—Paclitaxel—ovarian cancer	0.000183	0.00292	CcSEcCtD
Tolmetin—Body temperature increased—Paclitaxel—ovarian cancer	0.000183	0.00292	CcSEcCtD
Tolmetin—Epistaxis—Doxorubicin—ovarian cancer	0.000182	0.00289	CcSEcCtD
Tolmetin—Visual impairment—Epirubicin—ovarian cancer	0.00018	0.00287	CcSEcCtD
Tolmetin—Agranulocytosis—Doxorubicin—ovarian cancer	0.00018	0.00286	CcSEcCtD
Tolmetin—Erythema multiforme—Epirubicin—ovarian cancer	0.000177	0.00281	CcSEcCtD
Tolmetin—Somnolence—Docetaxel—ovarian cancer	0.000175	0.00279	CcSEcCtD
Tolmetin—Tinnitus—Epirubicin—ovarian cancer	0.000174	0.00277	CcSEcCtD
Tolmetin—Dyspepsia—Docetaxel—ovarian cancer	0.000173	0.00276	CcSEcCtD
Tolmetin—Hepatitis—Doxorubicin—ovarian cancer	0.000173	0.00275	CcSEcCtD
Tolmetin—Indomethacin—ABCB1—ovarian cancer	0.00017	0.163	CrCbGaD
Tolmetin—Constipation—Docetaxel—ovarian cancer	0.000168	0.00268	CcSEcCtD
Tolmetin—Visual impairment—Doxorubicin—ovarian cancer	0.000167	0.00265	CcSEcCtD
Tolmetin—Asthenia—Paclitaxel—ovarian cancer	0.000167	0.00265	CcSEcCtD
Tolmetin—Erythema multiforme—Doxorubicin—ovarian cancer	0.000163	0.0026	CcSEcCtD
Tolmetin—Tinnitus—Doxorubicin—ovarian cancer	0.000161	0.00257	CcSEcCtD
Tolmetin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000161	0.00256	CcSEcCtD
Tolmetin—Flatulence—Epirubicin—ovarian cancer	0.00016	0.00255	CcSEcCtD
Tolmetin—Diarrhoea—Paclitaxel—ovarian cancer	0.000159	0.00253	CcSEcCtD
Tolmetin—Abdominal pain—Docetaxel—ovarian cancer	0.000155	0.00248	CcSEcCtD
Tolmetin—Body temperature increased—Docetaxel—ovarian cancer	0.000155	0.00248	CcSEcCtD
Tolmetin—Dizziness—Paclitaxel—ovarian cancer	0.000153	0.00244	CcSEcCtD
Tolmetin—Flatulence—Doxorubicin—ovarian cancer	0.000148	0.00236	CcSEcCtD
Tolmetin—Vomiting—Paclitaxel—ovarian cancer	0.000148	0.00235	CcSEcCtD
Tolmetin—Headache—Paclitaxel—ovarian cancer	0.000145	0.00232	CcSEcCtD
Tolmetin—Asthenia—Docetaxel—ovarian cancer	0.000141	0.00225	CcSEcCtD
Tolmetin—Chest pain—Epirubicin—ovarian cancer	0.000138	0.0022	CcSEcCtD
Tolmetin—Nausea—Paclitaxel—ovarian cancer	0.000138	0.0022	CcSEcCtD
Tolmetin—Diarrhoea—Docetaxel—ovarian cancer	0.000135	0.00214	CcSEcCtD
Tolmetin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000133	0.00211	CcSEcCtD
Tolmetin—Oedema—Epirubicin—ovarian cancer	0.000133	0.00211	CcSEcCtD
Tolmetin—Dizziness—Docetaxel—ovarian cancer	0.00013	0.00207	CcSEcCtD
Tolmetin—Thrombocytopenia—Epirubicin—ovarian cancer	0.00013	0.00207	CcSEcCtD
Tolmetin—Chest pain—Doxorubicin—ovarian cancer	0.000128	0.00204	CcSEcCtD
Tolmetin—Vomiting—Docetaxel—ovarian cancer	0.000125	0.00199	CcSEcCtD
Tolmetin—Headache—Docetaxel—ovarian cancer	0.000123	0.00196	CcSEcCtD
Tolmetin—Oedema—Doxorubicin—ovarian cancer	0.000123	0.00196	CcSEcCtD
Tolmetin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000123	0.00196	CcSEcCtD
Tolmetin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00012	0.00191	CcSEcCtD
Tolmetin—Somnolence—Epirubicin—ovarian cancer	0.000118	0.00188	CcSEcCtD
Tolmetin—Nausea—Docetaxel—ovarian cancer	0.000117	0.00186	CcSEcCtD
Tolmetin—Dyspepsia—Epirubicin—ovarian cancer	0.000117	0.00186	CcSEcCtD
Tolmetin—Constipation—Epirubicin—ovarian cancer	0.000113	0.00181	CcSEcCtD
Tolmetin—Somnolence—Doxorubicin—ovarian cancer	0.000109	0.00174	CcSEcCtD
Tolmetin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000108	0.00173	CcSEcCtD
Tolmetin—Dyspepsia—Doxorubicin—ovarian cancer	0.000108	0.00172	CcSEcCtD
Tolmetin—Urticaria—Epirubicin—ovarian cancer	0.000105	0.00168	CcSEcCtD
Tolmetin—Constipation—Doxorubicin—ovarian cancer	0.000105	0.00167	CcSEcCtD
Tolmetin—Abdominal pain—Epirubicin—ovarian cancer	0.000105	0.00167	CcSEcCtD
Tolmetin—Body temperature increased—Epirubicin—ovarian cancer	0.000105	0.00167	CcSEcCtD
Tolmetin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.0001	0.0016	CcSEcCtD
Tolmetin—Urticaria—Doxorubicin—ovarian cancer	9.75e-05	0.00155	CcSEcCtD
Tolmetin—Abdominal pain—Doxorubicin—ovarian cancer	9.7e-05	0.00155	CcSEcCtD
Tolmetin—Body temperature increased—Doxorubicin—ovarian cancer	9.7e-05	0.00155	CcSEcCtD
Tolmetin—Asthenia—Epirubicin—ovarian cancer	9.52e-05	0.00152	CcSEcCtD
Tolmetin—Diarrhoea—Epirubicin—ovarian cancer	9.08e-05	0.00145	CcSEcCtD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ovarian cancer	8.93e-05	0.00119	CbGpPWpGaD
Tolmetin—Asthenia—Doxorubicin—ovarian cancer	8.81e-05	0.0014	CcSEcCtD
Tolmetin—Dizziness—Epirubicin—ovarian cancer	8.77e-05	0.0014	CcSEcCtD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	8.73e-05	0.00116	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—AKT1—ovarian cancer	8.71e-05	0.00116	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	8.59e-05	0.00114	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	8.56e-05	0.00114	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	8.55e-05	0.00113	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	8.54e-05	0.00113	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDKN1B—ovarian cancer	8.52e-05	0.00113	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—MAPK3—ovarian cancer	8.46e-05	0.00112	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TP53—ovarian cancer	8.46e-05	0.00112	CbGpPWpGaD
Tolmetin—Vomiting—Epirubicin—ovarian cancer	8.44e-05	0.00134	CcSEcCtD
Tolmetin—Diarrhoea—Doxorubicin—ovarian cancer	8.4e-05	0.00134	CcSEcCtD
Tolmetin—Headache—Epirubicin—ovarian cancer	8.31e-05	0.00132	CcSEcCtD
Tolmetin—TDO2—Metabolism—PPP2R1A—ovarian cancer	8.27e-05	0.0011	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—BCL9—ovarian cancer	8.21e-05	0.00109	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	8.16e-05	0.00108	CbGpPWpGaD
Tolmetin—Dizziness—Doxorubicin—ovarian cancer	8.12e-05	0.00129	CcSEcCtD
Tolmetin—PTGS2—Spinal Cord Injury—TLR4—ovarian cancer	8.11e-05	0.00108	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—HRAS—ovarian cancer	8.09e-05	0.00107	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	8.07e-05	0.00107	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—MAPK1—ovarian cancer	8.05e-05	0.00107	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	8.05e-05	0.00107	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—AKT1—ovarian cancer	7.94e-05	0.00105	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL6—ovarian cancer	7.93e-05	0.00105	CbGpPWpGaD
Tolmetin—Nausea—Epirubicin—ovarian cancer	7.88e-05	0.00126	CcSEcCtD
Tolmetin—Vomiting—Doxorubicin—ovarian cancer	7.81e-05	0.00124	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL6—ovarian cancer	7.75e-05	0.00103	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—ovarian cancer	7.75e-05	0.00103	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TP53—ovarian cancer	7.71e-05	0.00102	CbGpPWpGaD
Tolmetin—Headache—Doxorubicin—ovarian cancer	7.69e-05	0.00122	CcSEcCtD
Tolmetin—TDO2—Metabolism—ABCB1—ovarian cancer	7.68e-05	0.00102	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—TYMS—ovarian cancer	7.55e-05	0.001	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HSD17B6—ovarian cancer	7.41e-05	0.000984	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—AKT1—ovarian cancer	7.31e-05	0.000971	CbGpPWpGaD
Tolmetin—Nausea—Doxorubicin—ovarian cancer	7.29e-05	0.00116	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	7.28e-05	0.000967	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	7.18e-05	0.000953	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NME2—ovarian cancer	7.15e-05	0.00095	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL6—ovarian cancer	7.05e-05	0.000937	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN1B—ovarian cancer	7.05e-05	0.000936	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	7.05e-05	0.000936	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	7.05e-05	0.000936	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—STAT3—ovarian cancer	7.02e-05	0.000932	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—PIK3CA—ovarian cancer	6.99e-05	0.000928	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	6.92e-05	0.000919	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—MTOR—ovarian cancer	6.86e-05	0.000911	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	6.86e-05	0.000911	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CCND1—ovarian cancer	6.73e-05	0.000893	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—MAPK3—ovarian cancer	6.7e-05	0.00089	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—DOK1—ovarian cancer	6.49e-05	0.000862	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN1B—ovarian cancer	6.44e-05	0.000855	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—MAPK1—ovarian cancer	6.38e-05	0.000847	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—ovarian cancer	6.19e-05	0.000822	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PPP1CC—ovarian cancer	6.1e-05	0.00081	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CAV1—ovarian cancer	6.08e-05	0.000807	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.07e-05	0.000805	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CHMP4C—ovarian cancer	5.92e-05	0.000787	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—NRAS—ovarian cancer	5.79e-05	0.000769	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.71e-05	0.000759	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—AKT1—ovarian cancer	5.71e-05	0.000758	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NME2—ovarian cancer	5.68e-05	0.000754	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL6—ovarian cancer	5.64e-05	0.000749	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CG—ovarian cancer	5.54e-05	0.000735	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.52e-05	0.000733	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CXCL8—ovarian cancer	5.5e-05	0.000731	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—MYC—ovarian cancer	5.4e-05	0.000716	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	5.38e-05	0.000714	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CDKN1B—ovarian cancer	5.37e-05	0.000713	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—VEGFA—ovarian cancer	5.36e-05	0.000711	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—ovarian cancer	5.36e-05	0.000711	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—STAT3—ovarian cancer	5.3e-05	0.000704	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CASP3—ovarian cancer	5.27e-05	0.000699	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL2—ovarian cancer	5.26e-05	0.000698	CbGpPWpGaD
Tolmetin—PTGS2—Disease—BCL9—ovarian cancer	5.14e-05	0.000682	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CCND1—ovarian cancer	5.13e-05	0.000681	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	5.08e-05	0.000675	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—MAPK3—ovarian cancer	5.07e-05	0.000673	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—KRAS—ovarian cancer	4.99e-05	0.000662	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MMP9—ovarian cancer	4.98e-05	0.000661	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.94e-05	0.000657	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL6—ovarian cancer	4.92e-05	0.000654	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—IL6—ovarian cancer	4.9e-05	0.000651	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CD—ovarian cancer	4.87e-05	0.000646	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—MAPK1—ovarian cancer	4.82e-05	0.00064	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	4.82e-05	0.000639	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HDAC6—ovarian cancer	4.63e-05	0.000614	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYTB—ovarian cancer	4.61e-05	0.000612	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PPP2R1A—ovarian cancer	4.56e-05	0.000606	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.5e-05	0.000598	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.36e-05	0.000579	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CB—ovarian cancer	4.24e-05	0.000564	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—HRAS—ovarian cancer	4.24e-05	0.000563	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MAPK3—ovarian cancer	4.23e-05	0.000561	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MYC—ovarian cancer	4.11e-05	0.000546	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—YAP1—ovarian cancer	4.09e-05	0.000544	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—ovarian cancer	4.05e-05	0.000537	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPP1CC—ovarian cancer	4.03e-05	0.000535	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—BRIP1—ovarian cancer	4.03e-05	0.000535	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MAPK1—ovarian cancer	4.02e-05	0.000534	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—EGFR—ovarian cancer	4.02e-05	0.000534	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—XIAP—ovarian cancer	4.01e-05	0.000533	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	3.95e-05	0.000524	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.93e-05	0.000521	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SMARCA4—ovarian cancer	3.91e-05	0.000519	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL6—ovarian cancer	3.91e-05	0.000519	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PPP1CC—ovarian cancer	3.82e-05	0.000507	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EREG—ovarian cancer	3.81e-05	0.000507	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MMP2—ovarian cancer	3.71e-05	0.000493	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—IL6—ovarian cancer	3.7e-05	0.000492	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTEN—ovarian cancer	3.67e-05	0.000487	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYTB—ovarian cancer	3.66e-05	0.000486	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	3.65e-05	0.000485	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	3.58e-05	0.000476	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.58e-05	0.000475	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PGR—ovarian cancer	3.57e-05	0.000475	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	3.49e-05	0.000463	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	3.45e-05	0.000458	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—ovarian cancer	3.38e-05	0.000448	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	3.37e-05	0.000447	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CG—ovarian cancer	3.36e-05	0.000447	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PARP1—ovarian cancer	3.32e-05	0.000441	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—BRIP1—ovarian cancer	3.2e-05	0.000425	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPP1CC—ovarian cancer	3.2e-05	0.000425	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6ST—ovarian cancer	3.18e-05	0.000422	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL6—ovarian cancer	3.09e-05	0.00041	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CG—ovarian cancer	3.05e-05	0.000406	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	3.04e-05	0.000404	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CD—ovarian cancer	2.96e-05	0.000393	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.94e-05	0.00039	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HDAC6—ovarian cancer	2.89e-05	0.000384	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.88e-05	0.000382	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CTNNB1—ovarian cancer	2.84e-05	0.000378	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.8e-05	0.000371	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.74e-05	0.000363	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.74e-05	0.000363	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—YAP1—ovarian cancer	2.7e-05	0.000359	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PPP2R1A—ovarian cancer	2.7e-05	0.000358	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CD—ovarian cancer	2.68e-05	0.000357	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.67e-05	0.000355	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CA—ovarian cancer	2.59e-05	0.000344	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.58e-05	0.000343	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CB—ovarian cancer	2.58e-05	0.000342	CbGpPWpGaD
Tolmetin—PTGS2—Disease—XIAP—ovarian cancer	2.51e-05	0.000333	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SMARCA4—ovarian cancer	2.44e-05	0.000325	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EREG—ovarian cancer	2.39e-05	0.000317	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.37e-05	0.000315	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2—ovarian cancer	2.37e-05	0.000314	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.35e-05	0.000312	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CB—ovarian cancer	2.34e-05	0.000311	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.33e-05	0.000309	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.3e-05	0.000305	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—FASN—ovarian cancer	2.2e-05	0.000292	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC5A5—ovarian cancer	2.17e-05	0.000288	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2—ovarian cancer	2.15e-05	0.000285	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—YAP1—ovarian cancer	2.14e-05	0.000285	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TERT—ovarian cancer	2.14e-05	0.000284	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.12e-05	0.000282	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AKT1—ovarian cancer	2.11e-05	0.000281	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC2A1—ovarian cancer	2.09e-05	0.000278	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FASN—ovarian cancer	2.09e-05	0.000277	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PARP1—ovarian cancer	2.08e-05	0.000276	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.05e-05	0.000272	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP1B1—ovarian cancer	2.01e-05	0.000266	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SLC2A1—ovarian cancer	1.98e-05	0.000263	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CAV1—ovarian cancer	1.98e-05	0.000263	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.94e-05	0.000258	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ESR1—ovarian cancer	1.91e-05	0.000253	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6ST—ovarian cancer	1.88e-05	0.000249	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.87e-05	0.000248	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CG—ovarian cancer	1.8e-05	0.00024	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APC—ovarian cancer	1.8e-05	0.00024	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—NRAS—ovarian cancer	1.8e-05	0.00024	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPP2R1A—ovarian cancer	1.78e-05	0.000236	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.77e-05	0.000235	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—FASN—ovarian cancer	1.75e-05	0.000232	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MAPK3—ovarian cancer	1.73e-05	0.000229	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC5A5—ovarian cancer	1.72e-05	0.000228	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PPP2R1A—ovarian cancer	1.69e-05	0.000224	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC2A1—ovarian cancer	1.66e-05	0.000221	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ABCB1—ovarian cancer	1.65e-05	0.000219	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MAPK1—ovarian cancer	1.64e-05	0.000218	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EGFR—ovarian cancer	1.64e-05	0.000218	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.63e-05	0.000216	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—TYMS—ovarian cancer	1.62e-05	0.000215	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP1B1—ovarian cancer	1.59e-05	0.000211	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CD—ovarian cancer	1.59e-05	0.000211	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CA—ovarian cancer	1.57e-05	0.000209	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—KRAS—ovarian cancer	1.55e-05	0.000206	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CA—ovarian cancer	1.43e-05	0.000189	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPP2R1A—ovarian cancer	1.41e-05	0.000188	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.41e-05	0.000187	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ERBB2—ovarian cancer	1.4e-05	0.000186	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CB—ovarian cancer	1.38e-05	0.000184	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MTOR—ovarian cancer	1.38e-05	0.000184	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TERT—ovarian cancer	1.34e-05	0.000178	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HRAS—ovarian cancer	1.32e-05	0.000175	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ABCB1—ovarian cancer	1.31e-05	0.000174	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CAV1—ovarian cancer	1.31e-05	0.000174	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1B—ovarian cancer	1.3e-05	0.000172	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TYMS—ovarian cancer	1.29e-05	0.000171	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AKT1—ovarian cancer	1.28e-05	0.00017	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CASP3—ovarian cancer	1.27e-05	0.000169	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2—ovarian cancer	1.27e-05	0.000169	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—ovarian cancer	1.26e-05	0.000168	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.25e-05	0.000166	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CAV1—ovarian cancer	1.24e-05	0.000165	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCND1—ovarian cancer	1.24e-05	0.000164	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CTNNB1—ovarian cancer	1.23e-05	0.000163	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP9—ovarian cancer	1.2e-05	0.00016	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTEN—ovarian cancer	1.19e-05	0.000159	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CG—ovarian cancer	1.19e-05	0.000158	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6ST—ovarian cancer	1.17e-05	0.000156	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKT1—ovarian cancer	1.17e-05	0.000155	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APC—ovarian cancer	1.13e-05	0.00015	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—ovarian cancer	1.08e-05	0.000143	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STAT3—ovarian cancer	1.07e-05	0.000142	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NRAS—ovarian cancer	1.07e-05	0.000142	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CD—ovarian cancer	1.05e-05	0.000139	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CAV1—ovarian cancer	1.04e-05	0.000138	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK3—ovarian cancer	1.02e-05	0.000136	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MYC—ovarian cancer	9.93e-06	0.000132	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CD—ovarian cancer	9.92e-06	0.000132	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.91e-06	0.000132	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK1—ovarian cancer	9.71e-06	0.000129	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGFR—ovarian cancer	9.71e-06	0.000129	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CG—ovarian cancer	9.45e-06	0.000126	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KRAS—ovarian cancer	9.17e-06	0.000122	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CB—ovarian cancer	9.12e-06	0.000121	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ERBB2—ovarian cancer	8.76e-06	0.000116	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MTOR—ovarian cancer	8.65e-06	0.000115	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CB—ovarian cancer	8.65e-06	0.000115	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CA—ovarian cancer	8.43e-06	0.000112	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CD—ovarian cancer	8.31e-06	0.00011	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—ovarian cancer	8.15e-06	0.000108	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1B—ovarian cancer	8.12e-06	0.000108	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTEN—ovarian cancer	7.88e-06	0.000105	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HRAS—ovarian cancer	7.8e-06	0.000104	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CTNNB1—ovarian cancer	7.67e-06	0.000102	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PTEN—ovarian cancer	7.47e-06	9.92e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—ovarian cancer	7.46e-06	9.91e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CB—ovarian cancer	7.24e-06	9.62e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKT1—ovarian cancer	6.88e-06	9.14e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—STAT3—ovarian cancer	6.68e-06	8.87e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NRAS—ovarian cancer	6.67e-06	8.85e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAPK3—ovarian cancer	6.38e-06	8.48e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PTEN—ovarian cancer	6.26e-06	8.31e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MYC—ovarian cancer	6.21e-06	8.25e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAPK1—ovarian cancer	6.08e-06	8.07e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGFR—ovarian cancer	6.07e-06	8.07e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KRAS—ovarian cancer	5.74e-06	7.62e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CA—ovarian cancer	5.56e-06	7.38e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CA—ovarian cancer	5.27e-06	7e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HRAS—ovarian cancer	4.88e-06	6.48e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—ovarian cancer	4.67e-06	6.2e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKT1—ovarian cancer	4.54e-06	6.03e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CA—ovarian cancer	4.41e-06	5.86e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKT1—ovarian cancer	4.31e-06	5.72e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKT1—ovarian cancer	3.61e-06	4.79e-05	CbGpPWpGaD
